HeartBeam Income After Taxes 2020-2025 | BEAT

HeartBeam income after taxes from 2020 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
HeartBeam Annual Income After Taxes
(Millions of US $)
2024 $-19
2023 $-15
2022 $-13
2021 $-4
2020 $-1
2019 $-1
HeartBeam Quarterly Income After Taxes
(Millions of US $)
2025-03-31 $-5
2024-12-31 $-5
2024-09-30 $-5
2024-06-30 $-5
2024-03-31 $-5
2023-12-31 $-4
2023-09-30 $-3
2023-06-30 $-3
2023-03-31 $-4
2022-12-31 $-4
2022-09-30 $-4
2022-06-30 $-4
2022-03-31 $-2
2021-12-31 $-2
2021-09-30 $-1
2021-06-30 $-1
2021-03-31 $0
2020-12-31
2020-09-30 $0
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.043B $0.000B
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.813B 60.83
Hims & Hers Health (HIMS) United States $13.134B 136.46
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $10.733B 0.00
IRhythm Technologies (IRTC) United States $4.377B 0.00
Inspire Medical Systems (INSP) United States $3.856B 60.24
Hinge Health (HNGE) United States $3.535B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.803B 0.00
Schrodinger (SDGR) United States $1.643B 0.00
Phreesia (PHR) United States $1.614B 0.00
Azenta (AZTA) United States $1.562B 72.62
Enovis (ENOV) United States $1.561B 8.70
Clover Health Investments (CLOV) United States $1.527B 0.00
Omnicell (OMCL) United States $1.358B 23.97
Evolent Health (EVH) United States $1.133B 96.50
Claritev (CTEV) United States $0.664B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Standard BioTools (LAB) United States $0.539B 0.00
Veradigm (MDRX) United States $0.507B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.428B 128.00
TruBridge (TBRG) United States $0.347B 771.00
Outset Medical (OM) United States $0.320B 0.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.244B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.224B 0.00
CapsoVision (CV) United States $0.202B 0.00
Zepp Health (ZEPP) Netherlands $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.157B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
MDxHealth SA (MDXH) Belgium $0.120B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
PROFUSA (PFSA) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00